P53 binds to estrogen receptor 1 promoter in human breast cancer cells

Pathology and Oncology Research

Volumn 18, Issue 2, 2012, Pages 169-175

  Rasti, Mozhgan ^a   Arabsolghar, Rita ^a   Khatooni, Zahed ^a   Mostafavi Pour, Zoherh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Epigenetic; Estrogen receptor 1; Methylated promoter; p53

Indexed keywords

DNA METHYLTRANSFERASE 1; ESTROGEN RECEPTOR ALPHA; GENOMIC DNA; HISTONE DEACETYLASE 1; METHYL CPG BINDING PROTEIN 2; MUTANT PROTEIN; PROTEIN P53; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ESTROGEN RECEPTOR 1 GENE; GENE ACTIVATION; GENE CONTROL; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; WILD TYPE;

BLOTTING, WESTERN; BREAST NEOPLASMS; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 1; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MUTATION; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863474612     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9423-6     Document Type: Article

References (41)

1. Millau JF, Bastien N, Drouin R (2009) p53 transcriptional activities: a general overview and some thoughts. Mutat Res 681:118-133
2. Olsson A, Manzl C, Strasser A et al (2007) How important are post-translational modifications in p53 for selectivity in targetgene transcription and tumour suppression? Cell Death Differ 14:1561-1575
3. Harms K, Nozell S, Chen X (2004) The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci 61:822-842
4. Helton ES, Chen X (2007) p53 modulation of the DNA damage response. J Cell Biochem 100:883-896
5. Murphy M, Ahn J, Walker KK et al (1999) Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 13:2490-2501
6. Seto E, Usheva A, Zambetti GP et al (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci U S A 89:12028-12032
7. Amaral JD, Xavier JM, Steer CJ et al (2010) The role of p53 in apoptosis. Discov Med 9:145-152
8. Olivier M, Eeles R, Hollstein M et al (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607-614
9. Angeloni SV, Martin MB, Garcia-Morales P et al (2004) Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells. J Endocrinol 180:497-504
10. Luczak MW, Jagodzinski PP (2006) The role of DNA methylation in cancer development. Folia Histochem Cytobiol 44:143-154
11. Miremadi A, Oestergaard MZ, Pharoah PD, et al. (2007) Cancer genetics of epigenetic genes. Hum Mol Genet 16 Spec No 1:R28-R49.
12. Parrella P, Poeta ML, Gallo AP et al (2004) Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res 10:5349-5354
13. Costello JF, Fruhwald MC, Smiraglia DJ et al (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24:132-138
14. Sharma D, Blum J, Yang X et al (2005) Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Mol Endocrinol 19:1740-1751
15. Yan L, Nass SJ, Smith D et al (2003) Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Cancer Biol Ther 2:552-556
16. Yang X, Ferguson AT, Nass SJ et al (2000) Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. Cancer Res 60:6890-6894
17. Berns EM, Klijn JG, Smid M et al (1996) TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes Cancer 16:170-179
18. Giacinti L, Claudio PP, Lopez M et al (2006) Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 11:1-8
19. Suzuki M, Sunaga N, Shames DS et al (2004) RNA interferencemediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 64:3137-3143
20. Lapidus RG, Nass SJ, Butash KA et al (1998) Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res 58:2515-2519
21. Yan L, Yang X, Davidson NE (2001) Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer. J Mammary Gland Biol Neoplasia 6:183-192
22. Vinyals A, Peinado MA, Gonzalez-Garrigues M et al (1999) Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein. Gene Ther 6:22-33
23. Yang X, Phillips DL, Ferguson AT et al (2001) Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 61:7025-7029
24. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427-5440
25. Ho JS, Ma W, Mao DYet al (2005) p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol 25:7423-7431
26. Imbriano C, Gurtner A, Cocchiarella F et al (2005) Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol 25:3737-3751
27. Scoumanne A, Chen X (2006) The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases, is repressed by p53 via protein methyltransferases and is required for G1-S transition. Cancer Res 66:6271-6279
28. Sengupta S, Shimamoto A, Koshiji M et al (2005) Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene 24:1738-1748
29. Horvath MM, Wang X, Resnick MA et al (2007) Divergent evolution of human p53 binding sites: cell cycle versus apoptosis. PLoS Genet 3:e127
30. Wei CL, Wu Q, Vega VB et al (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219
31. Koutsodontis G, Tentes I, Papakosta P et al (2001) Sp1 plays a critical role in the transcriptional activation of the human cyclindependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J Biol Chem 276:29116-29125
32. Akaogi K, Nakajima Y, Ito I et al (2009) KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha. Oncogene 28:2894-2902
33. Shirley SH, Rundhaug JE, Tian J et al (2009) Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res 69:3405-3414
34. Esteve PO, Chin HG, Pradhan S (2005) Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc Natl Acad Sci U S A 102:1000-1005
35. Petitjean A, Mathe E, Kato S et al (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28:622-629
36. Li SY, Rong M, Iacopetta B (2006) Germ-line variants in methylgroup metabolism genes and susceptibility to DNA methylation in human breast cancer. Oncol Rep 15:221-225
37. Oshiro MM, Watts GS, Wozniak RJ et al (2003) Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 22:3624-3634
38. Dhar G, Banerjee S, Dhar K et al (2008) Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2. Cancer Res 68:4580-4587
39. Goh AM, Coffill CR, Lane DP (2011) The role of mutant p53 in human cancer. J Pathol 223:116-126
40. Bertheau P, Espie M, Turpin E et al (2008) TP53 status and response to chemotherapy in breast cancer. Pathobiology 75:132-139
41. Avila MA, Velasco JA, Cansado J et al (1994) Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 54:2424-2428